ArticleNPJ precision oncology2024
Intratumoral heterogeneity drives acquired therapy resistance in a patient with metastatic prostate cancer.
Dena P Rhinehart et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it